Expression of gastrin-releasing peptide receptors in endometrial cancer

Lyuba Levine, Joseph A. Licci, Courtney Townsend, Mark Hellmich

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

BACKGROUND: The Bombesin (BBS)-related peptide, gastrin-releasing peptide, and its cognate receptor are ectopically expressed by many cancers, in which they regulate tumor proliferation and metastasis. But, their role in endometrial cancers is unknown. The purpose of this study was to determine whether endometrial cancer cell lines express functional BBS receptors and to determine whether they were coupled to the regulation of vascular endothelial growth factor (VEGF-A) expression. STUDY DESIGN: Endometrial cancer cell lines (HEC-1A, KLE, and AN3CA) were cultured according to the recommendations of the American Tissue Culture Collection. Ishikawa cells were maintained in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum. Before BBS treatment, all cell lines were placed in serum-free, phenol-free media for 24 hours. BBS-stimulated increases in intracellular Ca2+ ([Ca2+]i) were used to assess functional BBS receptor status. VEGF-A mRNA expression was determined by Northern blotting. RESULTS: BBS (100 nM) stimulated an increase in [Ca2+]i in HEC-1A, Ishikawa, and KLE cells, indicating the presence of functional BBS receptors. This increase did not occur in AN3CA cells. BBS stimulated a time-dependent increase in VEGF-A mRNA expression in Ishikawa and KLE cells. Ishikawa cells exhibited a peak of VEGF-A mRNA expression between 8 and 12 hours with a partial decline by 24 hours. KLE cells showed a relatively small increase at 12 hours. In contrast, HEC-1A cells exhibited a high baseline level of VEGF-A mRNA expression and did not show a response to BBS. CONCLUSIONS: These data demonstrate that endometrial cancer cell lines express functional BBS receptors. In Ishikawa, KLE, and HEC-1A cells, BBS receptors are coupled to the regulation of VEGF-A mRNA expression.

Original languageEnglish (US)
Pages (from-to)898-904
Number of pages7
JournalJournal of the American College of Surgeons
Volume196
Issue number6
DOIs
StatePublished - Jun 1 2003

Fingerprint

Bombesin Receptors
Endometrial Neoplasms
Bombesin
Vascular Endothelial Growth Factor A
Messenger RNA
Cell Line
Gastrin-Releasing Peptide
Eagles
Phenol
Serum
Northern Blotting
Neoplasms
Neoplasm Metastasis
Peptides

ASJC Scopus subject areas

  • Surgery

Cite this

Expression of gastrin-releasing peptide receptors in endometrial cancer. / Levine, Lyuba; Licci, Joseph A.; Townsend, Courtney; Hellmich, Mark.

In: Journal of the American College of Surgeons, Vol. 196, No. 6, 01.06.2003, p. 898-904.

Research output: Contribution to journalArticle

@article{d1a9160c89f040069b6d758250bb0ac1,
title = "Expression of gastrin-releasing peptide receptors in endometrial cancer",
abstract = "BACKGROUND: The Bombesin (BBS)-related peptide, gastrin-releasing peptide, and its cognate receptor are ectopically expressed by many cancers, in which they regulate tumor proliferation and metastasis. But, their role in endometrial cancers is unknown. The purpose of this study was to determine whether endometrial cancer cell lines express functional BBS receptors and to determine whether they were coupled to the regulation of vascular endothelial growth factor (VEGF-A) expression. STUDY DESIGN: Endometrial cancer cell lines (HEC-1A, KLE, and AN3CA) were cultured according to the recommendations of the American Tissue Culture Collection. Ishikawa cells were maintained in Dulbecco's modified Eagle's medium plus 10{\%} fetal bovine serum. Before BBS treatment, all cell lines were placed in serum-free, phenol-free media for 24 hours. BBS-stimulated increases in intracellular Ca2+ ([Ca2+]i) were used to assess functional BBS receptor status. VEGF-A mRNA expression was determined by Northern blotting. RESULTS: BBS (100 nM) stimulated an increase in [Ca2+]i in HEC-1A, Ishikawa, and KLE cells, indicating the presence of functional BBS receptors. This increase did not occur in AN3CA cells. BBS stimulated a time-dependent increase in VEGF-A mRNA expression in Ishikawa and KLE cells. Ishikawa cells exhibited a peak of VEGF-A mRNA expression between 8 and 12 hours with a partial decline by 24 hours. KLE cells showed a relatively small increase at 12 hours. In contrast, HEC-1A cells exhibited a high baseline level of VEGF-A mRNA expression and did not show a response to BBS. CONCLUSIONS: These data demonstrate that endometrial cancer cell lines express functional BBS receptors. In Ishikawa, KLE, and HEC-1A cells, BBS receptors are coupled to the regulation of VEGF-A mRNA expression.",
author = "Lyuba Levine and Licci, {Joseph A.} and Courtney Townsend and Mark Hellmich",
year = "2003",
month = "6",
day = "1",
doi = "10.1016/S1072-7515(03)00290-4",
language = "English (US)",
volume = "196",
pages = "898--904",
journal = "Journal of the American College of Surgeons",
issn = "1072-7515",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Expression of gastrin-releasing peptide receptors in endometrial cancer

AU - Levine, Lyuba

AU - Licci, Joseph A.

AU - Townsend, Courtney

AU - Hellmich, Mark

PY - 2003/6/1

Y1 - 2003/6/1

N2 - BACKGROUND: The Bombesin (BBS)-related peptide, gastrin-releasing peptide, and its cognate receptor are ectopically expressed by many cancers, in which they regulate tumor proliferation and metastasis. But, their role in endometrial cancers is unknown. The purpose of this study was to determine whether endometrial cancer cell lines express functional BBS receptors and to determine whether they were coupled to the regulation of vascular endothelial growth factor (VEGF-A) expression. STUDY DESIGN: Endometrial cancer cell lines (HEC-1A, KLE, and AN3CA) were cultured according to the recommendations of the American Tissue Culture Collection. Ishikawa cells were maintained in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum. Before BBS treatment, all cell lines were placed in serum-free, phenol-free media for 24 hours. BBS-stimulated increases in intracellular Ca2+ ([Ca2+]i) were used to assess functional BBS receptor status. VEGF-A mRNA expression was determined by Northern blotting. RESULTS: BBS (100 nM) stimulated an increase in [Ca2+]i in HEC-1A, Ishikawa, and KLE cells, indicating the presence of functional BBS receptors. This increase did not occur in AN3CA cells. BBS stimulated a time-dependent increase in VEGF-A mRNA expression in Ishikawa and KLE cells. Ishikawa cells exhibited a peak of VEGF-A mRNA expression between 8 and 12 hours with a partial decline by 24 hours. KLE cells showed a relatively small increase at 12 hours. In contrast, HEC-1A cells exhibited a high baseline level of VEGF-A mRNA expression and did not show a response to BBS. CONCLUSIONS: These data demonstrate that endometrial cancer cell lines express functional BBS receptors. In Ishikawa, KLE, and HEC-1A cells, BBS receptors are coupled to the regulation of VEGF-A mRNA expression.

AB - BACKGROUND: The Bombesin (BBS)-related peptide, gastrin-releasing peptide, and its cognate receptor are ectopically expressed by many cancers, in which they regulate tumor proliferation and metastasis. But, their role in endometrial cancers is unknown. The purpose of this study was to determine whether endometrial cancer cell lines express functional BBS receptors and to determine whether they were coupled to the regulation of vascular endothelial growth factor (VEGF-A) expression. STUDY DESIGN: Endometrial cancer cell lines (HEC-1A, KLE, and AN3CA) were cultured according to the recommendations of the American Tissue Culture Collection. Ishikawa cells were maintained in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum. Before BBS treatment, all cell lines were placed in serum-free, phenol-free media for 24 hours. BBS-stimulated increases in intracellular Ca2+ ([Ca2+]i) were used to assess functional BBS receptor status. VEGF-A mRNA expression was determined by Northern blotting. RESULTS: BBS (100 nM) stimulated an increase in [Ca2+]i in HEC-1A, Ishikawa, and KLE cells, indicating the presence of functional BBS receptors. This increase did not occur in AN3CA cells. BBS stimulated a time-dependent increase in VEGF-A mRNA expression in Ishikawa and KLE cells. Ishikawa cells exhibited a peak of VEGF-A mRNA expression between 8 and 12 hours with a partial decline by 24 hours. KLE cells showed a relatively small increase at 12 hours. In contrast, HEC-1A cells exhibited a high baseline level of VEGF-A mRNA expression and did not show a response to BBS. CONCLUSIONS: These data demonstrate that endometrial cancer cell lines express functional BBS receptors. In Ishikawa, KLE, and HEC-1A cells, BBS receptors are coupled to the regulation of VEGF-A mRNA expression.

UR - http://www.scopus.com/inward/record.url?scp=0037647085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037647085&partnerID=8YFLogxK

U2 - 10.1016/S1072-7515(03)00290-4

DO - 10.1016/S1072-7515(03)00290-4

M3 - Article

C2 - 12788426

AN - SCOPUS:0037647085

VL - 196

SP - 898

EP - 904

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 6

ER -